Pharmacy staff-reported adaptations to naloxone provision and over the counter (OTC) syringe sales during the COVID-19 pandemic: experiences across multiple states and two pharmacy chains

Journal article

Peer reviewed

Traci C. Green, Joseph Silcox, Derek Bolivar, Mary Gray, Anthony S. Floyd, Adriane N. Irwin, Ryan N. Hansen, Daniel M. Hartung and Jeffrey Bratberg

Journal of the American Pharmacists Association

10/18/2023

PMID: 37863398

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

6 Record Views

Title: Pharmacy staff-reported adaptations to naloxone provision and over the counter (OTC) syringe sales during the COVID-19 pandemic: experiences across multiple states and two pharmacy chains
Creators: Traci C. Green - Brandeis University
Joseph Silcox - Brandeis University
Derek Bolivar - Brandeis University
Mary Gray
Anthony S. Floyd - University of Washington
Adriane N. Irwin - Oregon State University
Ryan N. Hansen - University of Washington
Daniel M. Hartung - Oregon State University
Jeffrey Bratberg - University of Rhode Island
Publication Details: Journal of the American Pharmacists Association
Identifiers: 9924292792301921
Academic Unit: Heller School for Social Policy and Management; Institute for Behavioral Health
Language: English
Resource Type: Journal article